Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis of 22,090 cases and 28,498 controls

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 259-265

  Mao, Chen ^a   Wang, Xi Wen ^a   He, Ben Fu ^a   Qiu, Li Xin ^b   Liao, Ru Yan ^a   Luo, Rong Cheng ^a   Chen, Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; CYP17; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 17; CYP17A1 PROTEIN, HUMAN; STEROID 17ALPHA MONOOXYGENASE;

ARTICLE; BREAST CANCER; CANCER RISK; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MENOPAUSE; PRIORITY JOURNAL; AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; BREAST NEOPLASMS; CASE CONTROL STUDY; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PATIENT SELECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MENOPAUSE; MODELS, GENETIC; ODDS RATIO; PATIENT SELECTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STEROID 17-ALPHA-HYDROXYLASE;

EID: 77953538492     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0695-4     Document Type: Article

References (52)

1. ST Brentano J Picado-Leonard SH Mellon CC Moore WL Miller 1990 Tissue-specific, cyclic adenosine 3,5-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells Mol Endocrinol 4 12 1972 1979 10.1210/mend-4-12-1972 1:CAS:528:DyaK3MXitVSrsr8%3D 1964490
2. EL Cavalieri DE Stack PD Devanesan R Todorovic I Dwivedy S Higginbotham SL Johansson KD Patil ML Gross JK Gooden R Ramanathan RL Cerny EG Rogan 1997 Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators Proc Natl Acad Sci USA 94 20 10937 10942 10.1073/pnas.94.20.10937 1:CAS:528:DyaK2sXmtlCntrY%3D 9380738 (Pubitemid 27430839)
3. RF Service 1998 New role for estrogen in cancer? Science 279 5357 1631 1633 10.1126/science.279.5357.1631 1:CAS:528:DyaK1cXhvVaht7o%3D 9518374 (Pubitemid 28164438)
4. YS Fan R Sasi C Lee JS Winter MR Waterman CC Lin 1992 Localization of the human CYP17 gene (cytochrome P450(17 alpha)) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding Genomics 14 4 1110 1111 10.1016/S0888-7543(05)80140-5 1:CAS:528:DyaK3sXhs1ahtrs%3D 1478654 (Pubitemid 23053056)
5. AH Carey D Waterworth K Patel D White J Little P Novelli S Franks R Williamson 1994 Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 Hum Mol Genet 3 10 1873 1876 10.1093/hmg/3.10.1873 1:CAS:528:DyaK2cXmslyitr0%3D 7849715
6. JT Kadonaga KA Jones R Tjian 1986 Promoter-specific activation of RNA polymerase II transcription by Sp1 Trends Biochem Sci 11 1 20 23 10.1016/0968-0004(86)90226-4 1:CAS:528:DyaL28XhsVarurc%3D
7. HS Feigelson GA Coetzee LN Kolonel RK Ross BE Henderson 1997 A polymorphism in the CYP17 gene increases the risk of breast cancer Cancer Res 57 6 1063 1065 1:CAS:528:DyaK2sXhvFOisL4%3D 9067272
8. AM Dunning CS Healey PD Pharoah NA Foster JM Lipscombe KL Redman DF Easton NE Day BA Ponder 1998 No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer Br J Cancer 77 11 2045 2047 1:STN:280:DyaK1czjtValtg%3D%3D 9667690
9. KJ Helzlsouer HY Huang PT Strickland S Hoffman AJ Alberg GW Comstock DA Bell 1998 Association between CYP17 polymorphisms and the development of breast cancer Cancer Epidemiol Biomarkers Prev 7 10 945 949 1:CAS:528: DyaK1cXntVChtLc%3D 9796641
10. A Weston CF Pan IJ Bleiweiss HB Ksieski N Roy N Maloney MS Wolff 1998 CYP17 genotype and breast cancer risk Cancer Epidemiol Biomarkers Prev 7 10 941 944 1:CAS:528:DyaK1cXntVChsb8%3D 9796640
11. M Bergman-Jungeström M Gentile AC Lundin S Wingren 1999 Association between CYP17 gene polymorphism and risk of breast cancer in young women Int J Cancer 84 4 350 353 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3. 0.CO;2-L 10404084 (Pubitemid 29337118)
12. CA Haiman SE Hankinson D Spiegelman GA Colditz WC Willett FE Speizer KT Kelsey DJ Hunter 1999 The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer Cancer Res 59 5 1015 1020 1:CAS:528:DyaK1MXhslemtbs%3D 10070957
13. CS Huang HD Chern KJ Chang CW Cheng SM Hsu CY Shen 1999 Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility Cancer Res 59 19 4870 4875 1:CAS:528:DyaK1MXmslWktLw%3D 10519398
14. V Nedelcheva Kristensen EK Haraldsen KB Anderson PE Lønning B Erikstein R Kåresen OS Gabrielsen AL Børresen-Dale 1999 CYP17 and breast cancer risk: the polymorphism in the 5 flanking area of the gene does not influence binding to Sp-1 Cancer Res 59 12 2825 2828 1:STN:280: DyaK1MzhtVGisQ%3D%3D 10383140
15. IE Young KM Kurian C Annink IH Kunkler VA Anderson BB Cohen ML Hooper AH Wyllie CM Steel 1999 A polymorphism in the CYP17 gene is associated with male breast cancer Br J Cancer 81 1 141 143 10.1038/sj.bjc.6690663 1:CAS:528:DyaK1MXmt12ht78%3D 10487625 (Pubitemid 29415504)
16. N Hamajima H Iwata Y Obata K Matsuo M Mizutani T Iwase S Miura K Okuma K Ohashi K Tajima 2000 No association of the 5 promoter region polymorphism of CYP17 with breast cancer risk in Japan Jpn J Cancer Res 91 9 880 885 1:CAS:528:DC%2BD3cXmvFKht7w%3D 11011114
17. ES Kuligina AV Togo EN Suspitsin MY Grigoriev KM Pozharisskiy OL Chagunava LM Berstein C Theillet KP Hanson EN Imyanitov 2000 CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women Cancer Lett 156 1 45 50 10.1016/S0304-3835(00)00436-5 1:CAS:528:DC%2BD3cXjslOrurk%3D 10840158 (Pubitemid 30326766)
18. K Mitrunen N Jourenkova V Kataja M Eskelinen VM Kosma S Benhamou H Vainio M Uusitupa A Hirvonen 2000 Steroid metabolism gene CYP17 polymorphism and the development of breast cancer Cancer Epidemiol Biomarkers Prev 9 12 1343 1348 1:CAS:528:DC%2BD3MXktFaitA%3D%3D 11142420
19. Y Miyoshi K Iwao N Ikeda C Egawa S Noguchi 2000 Genetic polymorphism in CYP17 and breast cancer risk in Japanese women Eur J Cancer 36 18 2375 2379 10.1016/S0959-8049(00)00334-8 1:CAS:528:DC%2BD3cXotlCgs70%3D 11094312
20. AB Spurdle JL Hopper GS Dite X Chen J Cui MR McCredie GG Giles MC Southey DJ Venter DF Easton G Chenevix-Trench 2000 CYP17 promoter polymorphism and breast cancer in Australian women under age forty years J Natl Cancer Inst 92 20 1674 1681 10.1093/jnci/92.20.1674 1:CAS:528:DC%2BD3cXnvV2mtb0%3D 11036113
21. HS Feigelson R McKean-Cowdin GA Coetzee DO Stram LN Kolonel BE Henderson 2001 Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates Cancer Res 61 2 785 789 1:CAS:528:DC%2BD3MXht1Gmt7g%3D 11212283
22. SE McCann KB Moysich JL Freudenheim CB Ambrosone PG Shields 2002 The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women J Nutr 132 10 3036 3041 1:CAS:528:DC%2BD38Xnsl2ksb0%3D 12368392
23. CB Ambrosone KB Moysich H Furberg JL Freudenheim ED Bowman S Ahmed S Graham JE Vena PG Shields 2003 CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors Breast Cancer Res 5 2 R45 R51 10.1186/bcr570 1:CAS:528:DC%2BD3sXjtlegt7g%3D 12631398
24. K Gudmundsdottir S Thorlacius JG Jonasson BF Sigfusson L Tryggvadottir JE Eyfjord 2003 CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status Br J Cancer 88 6 933 936 10.1038/sj.bjc.6600839 1:CAS:528:DC%2BD3sXitFegtrY%3D 12644832 (Pubitemid 36520882)
25. W Tan J Qi DY Xing XP Miao KF Pan L Zhang DX Lin 2003 Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women Zhonghua Zhong Liu Za Zhi 25 5 453 456 1:CAS:528:DC%2BD2cXntFShtL4%3D 14575568
26. AH Wu A Seow K Arakawa D Van Den Berg HP Lee MC Yu 2003 HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore Int J Cancer 104 4 450 457 10.1002/ijc.10957 1:CAS:528:DC%2BD3sXisVejt78%3D 12584742 (Pubitemid 36323915)
27. H Ahsan AS Whittemore Y Chen RT Senie SP Hamilton Q Wang I Gurvich RM Santella 2005 Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study Breast Cancer Res 7 1 R71 R81 10.1186/bcr951 1:CAS:528:DC%2BD2cXhtFGmsrnF 15642171
28. LA Hefler CB Tempfer C Grimm A Lebrecht E Ulbrich G Heinze S Leodolter C Schneeberger MW Mueller A Muendlein H Koelbl 2004 Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women Cancer 101 2 264 269 10.1002/cncr.20361 1:CAS:528: DC%2BD2cXmsVKlsLs%3D 15241822 (Pubitemid 38890828)
29. P Chacko B Rajan BS Mathew T Joseph MR Pillai 2004 CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer Breast Cancer 11 4 380 388 10.1007/BF02968046 15604994
30. JH Chang DM Gertig X Chen GS Dite MA Jenkins RL Milne MC Southey MR McCredie GG Giles G Chenevix-Trench JL Hopper AB Spurdle 2005 CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study Breast Cancer Res 7 4 R513 R521 10.1186/bcr1040 1:CAS:528:DC%2BD2MXls1Gjtbo%3D 15987458
31. K Einarsdóttir T Rylander-Rudqvist K Humphreys S Ahlberg G Jonasdottir E Weiderpass KS Chia M Ingelman-Sundberg I Persson J Liu P Hall S Wedrén 2005 CYP17 gene polymorphism in relation to breast cancer risk: a case-control study Breast Cancer Res 7 6 R890 R896 10.1186/bcr1319 16280037
32. DF Han X Zhou MB Hu W Xie ZF Mao DE Chen F Liu F Zheng 2005 Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study Chin Med J (Engl) 118 18 1507 1516 1:CAS:528:DC%2BD2MXhtF2nt7vN
33. JL Hopper VM Hayes AB Spurdle G Chenevix-Trench MA Jenkins RL Milne GS Dite AA Tesoriero MR McCredie GG Giles MC Southey 2005 A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer Hum Mutat 26 4 298 302 10.1002/humu.20237 1:CAS:528:DC%2BD2MXhtFegt7rF 16121340 (Pubitemid 41361796)
34. MH Shin KM Lee JH Yang SJ Nam JW Kim KY Yoo SK Park DY Noh SH Ahn B Kim D Kang 2005 Genetic polymorphism of CYP17 and breast cancer risk in Korean women Exp Mol Med 37 1 11 17 1:CAS:528:DC%2BD2MXis1Srurw%3D 15761247 (Pubitemid 40392982)
35. E Verla-Tebit S Wang-Gohrke J Chang-Claude 2005 CYP17 5-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study Breast Cancer Res 7 4 R455 R464 10.1186/bcr1027 1:CAS:528:DC%2BD2MXkt1Cjs78%3D 15987450
36. MB Hu W Xie B Xiong DF Han Y Li MH Feng YF Zhou 2006 Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women Zhonghua Liu Xing Bing Xue Za Zhi 27 4 351 355 1:CAS:528:DC%2BD2sXhtVekur7I 16875543
37. R Piller E Verla-Tebit S Wang-Gohrke J Linseisen J Chang-Claude 2006 CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans J Nutr 136 6 1596 1603 1:CAS:528: DC%2BD28Xlt1Wnuro%3D 16702327
38. A Chakraborty NS Murthy C Chintamani D Bhatnagar RS Mohil PC Sharma S Saxena 2007 CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients J Hum Genet 52 2 159 165 10.1007/s10038-006-0095-0 17235448 (Pubitemid 46185110)
39. VW Setiawan FR Schumacher CA Haiman DO Stram D Albanes D Altshuler G Berglund J Buring EE Calle F Clavel-Chapelon DG Cox JM Gaziano SE Hankinson RB Hayes BE Henderson J Hirschhorn R Hoover DJ Hunter R Kaaks LN Kolonel P Kraft J Ma L Le Marchand J Linseisen E Lund C Navarro K Overvad D Palli PH Peeters MC Pike E Riboli MJ Stampfer MJ Thun R Travis D Trichopoulos M Yeager RG Ziegler H Spencer Feigelson SJ Chanock 2007 CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol Biomarkers Prev 16 11 2237 2246 10.1158/1055-9965.EPI-07-0589 1:CAS:528:DC%2BD2sXhtlSmur3I 18006912 (Pubitemid 351196355)
40. Y Chen MD Gammon SL Teitelbaum JA Britton MB Terry S Shantakumar SM Eng Q Wang I Gurvich AI Neugut RM Santella H Ahsan 2008 Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project Carcinogenesis 29 4 766 771 10.1093/carcin/bgn042 1:CAS:528:DC%2BD1cXktlOhtb4%3D 18281250 (Pubitemid 351494164)
41. LC Sakoda C Blackston JA Doherty RM Ray MG Lin H Stalsberg DL Gao Z Feng DB Thomas C Chen 2008 Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women Cancer Epidemiol Biomarkers Prev 17 5 1066 1073 10.1158/1055-9965.EPI-07-2680 1:CAS:528:DC%2BD1cXmtVClsLo%3D 18483327
42. C Torresan MM Oliveira GT Torrezan SF de Oliveira CS Abuázar R Losi-Guembarovski RS Lima CA Urban IJ Cavalli EM Ribeiro 2008 Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes Clin Exp Med 8 2 65 71 10.1007/s10238-008-0159-x 1:CAS:528:DC%2BD1cXosVequrs%3D 18618215 (Pubitemid 351999724)
43. L Zhang L Gu B Qian X Hao W Zhang Q Wei K Chen 2009 Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women Breast Cancer Res Treat 114 2 327 338 10.1007/s10549-008-9998-0 1:CAS:528:DC%2BD1MXhsFWnu7w%3D 18629629
44. C Antognelli C Del Buono V Ludovini S Gori VN Talesa L Crinò F Barberini A Rulli 2009 CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study BMC Cancer 9 115 10.1186/1471-2407-9-115 19379515
45. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1-34-T>C polymorphism. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0490-2
46. M Samson R Rama R Swaminathan V Sridevi KN Nancy T Rajkumar 2009 CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women Asian Pac J Cancer Prev 10 1 111 114 19469636
47. S Sangrajrang Y Sato H Sakamoto S Ohnami NM Laird T Khuhaprema P Brennan P Boffetta T Yoshida 2009 Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women Int J Cancer 125 4 837 843 10.1002/ijc.24434 1:CAS:528:DC%2BD1MXnsFeltLw%3D 19415745
48. Z Ye JM Parry 2002 The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis Mutagenesis 17 2 119 126 10.1093/mutage/17.2.119 1:CAS:528:DC%2BD38XitlSqsrk%3D 11880540
49. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 1 101 129 10.2307/3001666
50. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 4 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
51. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 3 177 188 10.1016/0197-2456(86)90046-2 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
52. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563